Search Results - "Craig, Sandra"

Refine Results
  1. 1

    Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE by Craig, Sandra N., Baxter, Merissa, Chapagai, Danda, Stafford, Jessy M., Nurmemmedov, Elmar, Altomare, Diego, Wyatt, Michael D., McInnes, Campbell

    Published in European journal of medicinal chemistry (05-01-2022)
    “…Polo-like kinase 1 (PLK1) is a serine/threonine-protein kinase involved in cell cycle regulation and mitotic progression. Studies have shown that PLK1 is…”
    Get full text
    Journal Article
  2. 2

    Synthesis and evaluation of aryl boronic acids as fluorescent artificial receptors for biological carbohydrates by Craig, Sandra

    Published in Bioorganic chemistry (01-02-2012)
    “…[Display omitted] ▸ Aryl boronic acid compounds serving as artificial receptors for biological carbohydrates. ▸ Boronic acid rapidly and reversibly bind to 1,2…”
    Get full text
    Journal Article
  3. 3

    Current assessment of polo-like kinases as anti-tumor drug targets by Craig, Sandra N, Wyatt, Michael D, McInnes, Campbell

    Published in Expert opinion on drug discovery (01-07-2014)
    “…Polo-like kinase (PLK)1 is the most studied of the PLK family and is a serine/threonine kinase that plays pivotal roles in many aspects of mitosis and hence…”
    Get more information
    Journal Article
  4. 4

    Benzamide capped peptidomimetics as non-ATP competitive inhibitors of CDK2 using the REPLACE strategy by Premnath, Padmavathy Nandha, Craig, Sandra N., Liu, Shu, McInnes, Campbell

    Published in Bioorganic & medicinal chemistry letters (01-08-2016)
    “…[Display omitted] Inhibition of cyclin dependent kinase 2 (CDK2) in complex with cyclin A in G1/S phase of the cell cycle has been shown to promote selective…”
    Get full text
    Journal Article
  5. 5

    Iterative Conversion of Cyclin Binding Groove Peptides into Druglike CDK Inhibitors with Antitumor Activity by Premnath, Padmavathy Nandha, Craig, Sandra N., Liu, Shu, Anderson, Erin L., Grigoroudis, Asterios I., Kontopidis, George, Perkins, Tracy L., Wyatt, Michael D., Pittman, Douglas L., McInnes, Campbell

    Published in Journal of medicinal chemistry (08-01-2015)
    “…The cyclin groove is an important recognition site for substrates of the cell cycle cyclin dependent kinases and provides an opportunity for highly selective…”
    Get full text
    Journal Article
  6. 6

    Abstract 1241: Converting high affinity peptides to non-peptidic inhibitors via REPLACE: Novel and new strategies in targeting PLK1 Polo Box Domain (PBD) for anti-cancer therapy by Chapagai, Danda, Ramamoorthy, Guru, Baxter, Merissa, Craig, Sandra, Nurmemmedov, Elmar, Campbell, McInnes, Wyatt, Michael

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Polo Like Kinase 1 (PLK1) is only expressed in dividing cells and plays a critical role in several stages of mitosis. PLK1 is highly expressed in tumors of…”
    Get full text
    Journal Article
  7. 7

    Peptidomimetic Polo‐Box‐Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor by Baxter, Merissa, Chapagai, Danda, Craig, Sandra, Hurtado, Cecilia, Varghese, Jessy, Nurmemmedov, Elmar, Wyatt, Michael D., McInnes, Campbell

    Published in ChemMedChem (17-06-2020)
    “…The polo‐box domain (PBD) of PLK1 determines mitotic substrate recognition and subcellular localization. Compounds that target PLK1 selectively are required…”
    Get full text
    Journal Article
  8. 8

    Gold-Containing Indoles as Anticancer Agents That Potentiate the Cytotoxic Effects of Ionizing Radiation by Craig, Sandra, Gao, Lei, Lee, Irene, Gray, Thomas, Berdis, Anthony J

    Published in Journal of medicinal chemistry (08-03-2012)
    “…This report describes the design and application of several distinct gold-containing indoles as anticancer agents. When used individually, all gold-bearing…”
    Get full text
    Journal Article
  9. 9

    Abstract 4574: Polo box-targeted PLK1 inhibitors: structure activity relationships and activity in cells resistant to ATP-based inhibitors by Baxer, Merissa, Craig, Sandra, McInnes, Campbell, Wyatt, Michael

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Polo-like Kinase 1 (PLK1) performs critical roles in the coordination of mitosis. PLK1 is also an oncogene over-expressed in many cancer types and is being…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Abstract 2572: A novel strategy for PLK1 kinase inhibition by allosterically targeting the Polo Box Domain by Chapagai, Danda, Baxter, Merissa, Craig, Sandra, Ramamoorthy, Guru, Stafford, Jessy, Vitali, Sikirzhytski, Nurmemmedov, Elmar, McInnes, Campbell, Wyatt, Michael D.

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Polo Like Kinase 1 (PLK1) is only expressed in dividing cells and plays a critical role in several stages of mitosis. PLK1 is overexpressed in many tumor…”
    Get full text
    Journal Article
  12. 12

    Abstract 2156: Targeting polo-like kinase 1 with novel inhibitors of the polo-box domain by Baxter, Merissa, Craig, Sandra, McInnes, Campbell, Wyatt, Michael D.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Polo-like Kinase 1 (PLK1) is a central player in cell cycle regulation and mitotic progression. Observations that PLK1 is over-expressed in many cancer types…”
    Get full text
    Journal Article
  13. 13

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors by Nandha Premnath, Padmavathy, Craig, Sandra, McInnes, Campbell

    Published in Journal of visualized experiments (26-10-2015)
    “…REPLACE is a unique strategy developed to more effectively target protein-protein interactions (PPIs). It aims to expand available drug target space by…”
    Get full text
    Journal Article
  14. 14

    Expression and genomic structure of the genes encoding FdI, the major allergen from the domestic cat by Griffith, I J, Craig, S, Pollock, J, Yu, X B, Morgenstern, J P, Rogers, B L

    Published in Gene (15-04-1992)
    “…The genes encoding chain 1 (Ch1) and chain 2 (Ch2) of the major allergen of the domestic cat, Felis domesticus I, have been analyzed by genomic cloning and by…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Gold-Containing Indoles as Anti-Cancer Agents that Potentiate the Cytotoxic Effects of Ionizing Radiation by Craig, Sandra, Gao, Lei, Lee, Irene, Gray, Thomas, Berdis, Anthony J.

    Published in Journal of medicinal chemistry (15-02-2012)
    “…This report describes the design and application of several distinct gold-containing indoles as anti-cancer agents. When used individually, all gold-bearing…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Active-Site-Directed Chemical Tools for Profiling Mitochondrial Lon Protease by Fishovitz, Jennifer, Li, Min, Frase, Hilary, Hudak, Jason, Craig, Sandra, Ko, Kristin, Berdis, Anthony J, Suzuki, Carolyn K, Lee, Irene

    Published in ACS chemical biology (19-08-2011)
    “…Lon and ClpXP are the only soluble ATP-dependent proteases within the mammalian mitochondria matrix, which function in protein quality control by selectively…”
    Get full text
    Journal Article
  19. 19

    Emergency department management of patients with automatic implantable cardioverter-defibrillators by Craig, S A, Hudson, A D

    Published in Annals of emergency medicine (01-04-1990)
    “…The case of a patient with idiopathic dilated cardiomyopathy and complex ventricular arrhythmias who underwent placement of an automatic implantable…”
    Get more information
    Journal Article
  20. 20

    Patients with Alcohol Problems in the Emergency Department, Part 1: Improving Detection by D'Onofrio, Gail, Bernstein, Edward, Bernstein, Judith, Woolard, Robert H., Brewer, Phillip A., Craig, Sandra A., Zink, Brian J.

    Published in Academic emergency medicine (01-12-1998)
    “… Medical and social problems related to alcohol use are frequently seen in the ED. Often, the tempo of emergency medicine practice seems to preclude…”
    Get full text
    Journal Article